Skip to main content
Fagron N.V. logo

Fagron N.V. — Investor Relations & Filings

Ticker · FAGR ISIN · BE0003874915 LEI · 549300TRKRUFK2RRG779 BR Manufacturing
Open in API
Filings indexed 1,979 across all filing types
Latest filing 2026-05-12 Declaration of Voting R…
Country BE Belgium
Listing BR FAGR

About Fagron N.V.

https://fagron.com/

Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.

Recent filings

Filing Released Lang Actions
Fagron shareholders approve all proposed resolutions at the General Meetings
Declaration of Voting Results & Voting Rights Announcements Classification · 89% confidence The document is a press release announcing the resolutions approved at Fagron’s Annual and Extraordinary General Meetings, including approval of annual accounts, dividend distribution, director appointments, and capital authorisation. This is a declaration of shareholder voting results at general meetings. It does not provide detailed financial statements (so it’s not an Annual Report or Interim Report) nor is it a simple publication notice. Therefore, it best fits “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-12 English
Fagron shareholders approve all proposed resolutions at the General Meetings
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release (“Persbericht”) announcing the results of Fagron’s Ordinary and Extraordinary General Meetings of Shareholders. It lists all resolutions approved (annual accounts, dividends, board appointments, capital authorization renewal) and the dividend calendar. This is clearly an announcement of shareholder voting results, matching the Declaration of Voting Results & Voting Rights category (DVA), rather than a full report or report publication notice.
2026-05-12 Dutch
Press release - 20260511 - Voting results AGM EGM 2026.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release reporting the approval of all proposed resolutions at the Annual and Extraordinary General Meetings, detailing dividend approval, director appointments, and authorised capital renewal. It announces the official voting results of shareholder resolutions. This aligns with Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-11 English
Persbericht - 20260511 - Stemresultaten GAV-BAV 2026.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a regulated press release announcing that at the Ordinary and Extraordinary General Meetings all proposed shareholder resolutions were approved, including approval of the annual accounts, dividend, board appointments, and authorization renewals. This is a publication of voting results from a general meeting, fitting the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2026-05-11 Dutch
Disclosure of transparency notification from BlackRock, Inc.
Regulatory Filings
2026-05-01 English
Disclosure of transparency notification from BlackRock, Inc.
Regulatory Filings
2026-05-01 Dutch

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.